Metal-organic frameworks for multimodal bioimaging and synergistic cancer chemotherapy
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Abstract Metal-organic frameworks (MOFs) are a novel class of porous materials made from metal ions and organic ligands, and have been widely explored as multifunctional nanoplatforms. MOFs present unique physicochemical characteristics, such as large surface area, tunable size and structure, and easy modification, thereby making them promising candidates for drug delivery, biomedical imaging, and therapeutic applications. Simultaneous utilization of organic linkers and various metal ions as the coordination centers provides possibility to generate multifunctional MOFs with a number of advantages. This feature article summarizes the development and modification of MOFs with emphasis on the recent progress of chemotherapy-based synergistic combination therapy and bioimaging techinques, including computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET) and optical imaging (OI). Future prospects and challenges of MOFs in the research of translational medicine are also discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Otto Warburg's contributions to current concepts of cancer metabolism
Koppenol, W. H., Bounds, P. L., & Dang, C. V. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3038 · Cited by 3,427
Hypoxia, HIF1 and glucose metabolism in the solid tumour
Denko, N. C. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2468 · Cited by 1,707
Lear, S. A., Hu, W., Rangarajan, S., Gasevic, D., Leong, D., Iqbal, R., Casanova, A., Swaminathan, S., Anjana, R. M., Kumar, R., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31634-3 · Cited by 1,331
Danhier, F. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.11.015 · Cited by 1,288
Maeda, H. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.01.002 · Cited by 1,179
Hellmann, M. D., Nathanson, T., Rizvi, H., Creelan, B. C., Sanchez-Vega, F., Ahuja, A., Ni, A., Novik, J. B., Mangarin, L. M. B., Abu-Akeel, M., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.018 · Cited by 1,095
Large-scale physical activity data reveal worldwide activity inequality
Althoff, T., Sosič, R., Hicks, J. L., King, A. C., Delp, S. L., & Leskovec, J. (2017) · Nature · doi:10.1038/nature23018 · Cited by 1,000
Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis
Conforti, F., Pala, L., Bagnardi, V., De Pas, T., Martinetti, M., Viale, G., Gelber, R. D., & Goldhirsch, A. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30261-4 · Cited by 973
Cheng, Y., Cheng, H., Jiang, C., Qiu, X., Wang, K., Huan, W., Yuan, A., Wu, J., & Hu, Y. (2015) · Nature Communications · doi:10.1038/ncomms9785 · Cited by 941
He, C., Lu, K., Liu, D., & Lin, W. (2014) · Journal of the American Chemical Society · doi:10.1021/ja4098862 · Cited by 885
Gold nanoparticles for applications in cancer radiotherapy: Mechanisms and recent advancements
Her, S., Jaffray, D. A., & Allen, C. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.12.012 · Cited by 865
Nichols, J. W., & Bae, Y. H. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.03.057 · Cited by 834
25th Anniversary Article: Hybrid Nanostructures Based on Two‐Dimensional Nanomaterials
Huang, X., Tan, C., Yin, Z., & Zhang, H. (2014) · Advanced Materials · doi:10.1002/adma.201304964 · Cited by 632
Drug self-delivery systems for cancer therapy
Qin, S.-Y., Zhang, A.-Q., Cheng, S.-X., Rong, L., & Zhang, X.-Z. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2016.10.016 · Cited by 532
Zhou, J., Li, M., Hou, Y., Luo, Z., Chen, Q., Cao, H., Huo, R., Xue, C., Sutrisno, L., Hao, L., et al. (2018) · ACS Nano · doi:10.1021/acsnano.8b00309 · Cited by 424
Wuttke, S., Lismont, M., Escudero, A., Rungtaweevoranit, B., & Parak, W. J. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.01.025 · Cited by 286
Cellular senescence: Immunosurveillance and future immunotherapy
Burton, D. G. A., & Stolzing, A. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.02.001 · Cited by 221
Modulating tumor hypoxia by nanomedicine for effective cancer therapy
Jahanban‐Esfahlan, R., de la Guardia, M., Ahmadi, D., & Yousefi, B. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.25859 · Cited by 201
Targeting cancer metabolism by simultaneously disrupting parallel nutrient access pathways
Kim, S. M., Roy, S. G., Chen, B., Nguyen, T. M., McMonigle, R. J., McCracken, A. N., Zhang, Y., Kofuji, S., Hou, J., Selwan, E., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci87148 · Cited by 77
Cited by
Metal–Organic Frameworks for Biomedical Applications
Yang, J., & Yang, Y. (2020) · Small · doi:10.1002/smll.201906846 · Cited by 998
Recent progress of chemodynamic therapy-induced combination cancer therapy
Wang, X., Zhong, X., Liu, Z., & Cheng, L. (2020) · Nano Today · doi:10.1016/j.nantod.2020.100946 · Cited by 711
Design and Applications of Water-Soluble Coordination Cages
Percástegui, E. G., Ronson, T. K., & Nitschke, J. R. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00672 · Cited by 590
Conferring Ti‐Based MOFs with Defects for Enhanced Sonodynamic Cancer Therapy
Liang, S., Xiao, X., Bai, L., Liu, B., Yuan, M., Ma, P., Pang, M., Cheng, Z., & Lin, J. (2021) · Advanced Materials · doi:10.1002/adma.202100333 · Cited by 359
Nanoscale covalent organic frameworks: from controlled synthesis to cancer therapy
He, X., Jiang, Z., Akakuru, O. U., Li, J., & Wu, A. (2021) · Chemical Communications · doi:10.1039/d1cc04846e · Cited by 303
Metadata
- Authors
- Zhang, Z., Sang, W., Xie, L., & Dai, Y.
- Venue
- Coordination Chemistry Reviews
- Publisher
- Elsevier BV
- Published
- 2019-11
- Volume
- 399
- Pages
- 213022
- ISSN
- 0010-8545 (ISSN-L)
- OpenAlex
- W2969220851
- Cited by
- 156
- References
- 19
- FWCI
- 7.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.